
Research Manitoba Announces New Initiative in Collaboration with the pharmaceutical and health tech industry for patients living with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia in Manitoba
Research Manitoba, Novartis Canada and MindSet are collaborating on a new research project to evaluate and identify the most effective strategy to lowering LDL-C and treatment costs for ASCVD and FH patients in Manitoba.